ABG complete learning

Reading File
Finding Sources
Finding Sources
Finding Sources
Searching Images

arterial blood gas ABG interpretation diagram acid base

A clinical photograph of a printed arterial blood gas (ABG) analysis report. The document displays measured and calculated physiological values at a patient temperature of 37.0°C. Key measured values include a pH of 7.480, pCO2 of 22.3 mmHg, pO2 of 330.6 mmHg, and electrolyte levels (Na+ 143.4 mmol/L, K+ 3.28 mmol/L, Ca++ 1.03 mmol/L). Calculated values show a bicarbonate (HCO3-) level of 16.8 mmol/L and an oxygen saturation (SO2%) of 100.0%. This visual demonstrates a 'saturation gap' characteristic of certain toxicological conditions, such as methemoglobinemia, where the calculated oxygen saturation from the ABG appears normal (100%) despite the patient potentially experiencing clinical cyanosis and low peripheral pulse oximetry readings. The image is an educational tool for critical care, emergency medicine, and clinical toxicology, illustrating the interpretation of acid-base balance and oxygenation status.

A clinical photograph of a printed arterial blood gas (ABG) analysis report. The document displays measured and calculated physiological values at a patient temperature of 37.0°C. Key measured values include a pH of 7.480, pCO2 of 22.3 mmHg, pO2 of 330.6 mmHg, and electrolyte levels (Na+ 143.4 mmol/L, K+ 3.28 mmol/L, Ca++ 1.03 mmol/L). Calculated values show a bicarbonate (HCO3-) level of 16.8 mmol/L and an oxygen saturation (SO2%) of 100.0%. This visual demonstrates a 'saturation gap' characteristic of certain toxicological conditions, such as methemoglobinemia, where the calculated oxygen saturation from the ABG appears normal (100%) despite the patient potentially experiencing clinical cyanosis and low peripheral pulse oximetry readings. The image is an educational tool for critical care, emergency medicine, and clinical toxicology, illustrating the interpretation of acid-base balance and oxygenation status.

This medical anatomical diagram illustrates the arterial blood supply and vascular distribution patterns across the internal skull base, specifically focusing on feeders involved in skull base meningiomas. The composite image consists of five sub-figures (A-E) superimposed on a superior view of a human skull model. Sub-figure A depicts the Dorsal Meningeal Artery (DMA) in red, originating from the meningohypophyseal trunk and descending along the upper clivus. Sub-figure B shows the Ascending Pharyngeal Artery (APA) in orange, distributing around the foramen magnum and lower clivus. Sub-figure C highlights the Tentorial Artery (TA) in green, following the course of the tentorium cerebelli. Sub-figure D illustrates the Petrosal Branch (PB) in blue, arising from the middle meningeal artery near the foramen spinosum and reaching the petrous apex. Sub-figure E provides a summarized color-coded overlay demonstrating the spatial relationships of these four vascular territories relative to the clivus, petrous bone, and foramen magnum. This visual guide assists in identifying potential feeding arteries based on the tumor's dural attachment site during preoperative planning for meningioma resection.

This medical anatomical diagram illustrates the arterial blood supply and vascular distribution patterns across the internal skull base, specifically focusing on feeders involved in skull base meningiomas. The composite image consists of five sub-figures (A-E) superimposed on a superior view of a human skull model. Sub-figure A depicts the Dorsal Meningeal Artery (DMA) in red, originating from the meningohypophyseal trunk and descending along the upper clivus. Sub-figure B shows the Ascending Pharyngeal Artery (APA) in orange, distributing around the foramen magnum and lower clivus. Sub-figure C highlights the Tentorial Artery (TA) in green, following the course of the tentorium cerebelli. Sub-figure D illustrates the Petrosal Branch (PB) in blue, arising from the middle meningeal artery near the foramen spinosum and reaching the petrous apex. Sub-figure E provides a summarized color-coded overlay demonstrating the spatial relationships of these four vascular territories relative to the clivus, petrous bone, and foramen magnum. This visual guide assists in identifying potential feeding arteries based on the tumor's dural attachment site during preoperative planning for meningioma resection.

Anatomical Diagram and intraoperative overlay illustrating the arterial blood supply to the cavernous sinus, specifically regarding the feeding vessels of skull base meningiomas. The cavernous sinus is highlighted by a pink outline. The arterial distribution is color-coded: the Tentorial Artery (TA) is represented in yellow, demonstrating its supply to the superolateral aspect of the posterior cavernous sinus. The Dural Meningeal Artery (DMA) is shown in blue, highlighting its coverage of the inferomedial portion of the posterior cavernous sinus. A red arrow identifies the interface where cranial nerves are typically situated between these two arterial territories. The image serves as a clinical reference for neurosurgical planning, helping to differentiate between petrotentorial and petroclival meningioma attachments based on their primary feeding arteries and their spatial relationship to critical neurovascular structures within the skull base.

Anatomical Diagram and intraoperative overlay illustrating the arterial blood supply to the cavernous sinus, specifically regarding the feeding vessels of skull base meningiomas. The cavernous sinus is highlighted by a pink outline. The arterial distribution is color-coded: the Tentorial Artery (TA) is represented in yellow, demonstrating its supply to the superolateral aspect of the posterior cavernous sinus. The Dural Meningeal Artery (DMA) is shown in blue, highlighting its coverage of the inferomedial portion of the posterior cavernous sinus. A red arrow identifies the interface where cranial nerves are typically situated between these two arterial territories. The image serves as a clinical reference for neurosurgical planning, helping to differentiate between petrotentorial and petroclival meningioma attachments based on their primary feeding arteries and their spatial relationship to critical neurovascular structures within the skull base.

This medical anatomical diagram illustrates the arterial blood supply territories of the human brain through color-coded mapping on axial and coronal sections. Image 'a' displays an axial section at the level of the genu of the corpus callosum, while image 'b' shows a coronal section at the level of the head of the caudate nucleus. The primary vascular territories are identified as follows: red represents the Anterior Cerebral Artery (ACA), supplying the superior and medial aspects; green denotes the Middle Cerebral Artery (MCA), covering the extensive lateral and central regions; and blue indicates the Posterior Cerebral Artery (PCA) territory at the base and posterior aspects. Additionally, smaller vascular zones are identified, including the anterior choroidal artery (purple in 'a', light blue in 'b') and the posterior communicating artery (orange). Blue arrows highlight the border zones or watershed regions between major territories, which are clinically significant as areas highly susceptible to ischemia during hypoperfusion. This visual resource is designed for medical students and clinicians to understand neurovascular anatomy and the pathophysiology of watershed strokes.

This medical anatomical diagram illustrates the arterial blood supply territories of the human brain through color-coded mapping on axial and coronal sections. Image 'a' displays an axial section at the level of the genu of the corpus callosum, while image 'b' shows a coronal section at the level of the head of the caudate nucleus. The primary vascular territories are identified as follows: red represents the Anterior Cerebral Artery (ACA), supplying the superior and medial aspects; green denotes the Middle Cerebral Artery (MCA), covering the extensive lateral and central regions; and blue indicates the Posterior Cerebral Artery (PCA) territory at the base and posterior aspects. Additionally, smaller vascular zones are identified, including the anterior choroidal artery (purple in 'a', light blue in 'b') and the posterior communicating artery (orange). Blue arrows highlight the border zones or watershed regions between major territories, which are clinically significant as areas highly susceptible to ischemia during hypoperfusion. This visual resource is designed for medical students and clinicians to understand neurovascular anatomy and the pathophysiology of watershed strokes.

A surgical illustration depicting orthotopic renal transplantation, specifically focusing on the arterial clamping technique. The diagram shows the abdominal aorta as a central, vertical cylindrical vessel. A Satinsky surgical clamp is applied to the aorta, positioned precisely at the base of the left renal artery. This selective clamping method is designed to occlude blood flow for the creation of an anastomotic opening (approximately 8 mm from the artery base) while purposefully sparing the mesenteric arteries and the right renal artery, which are visible branching superiorly to the clamped segment. The illustration highlights the relationship between the surgical instrumentation and vascular anatomy to maintain systemic circulation and prevent lower limb or contralateral renal ischemia during the procedure. Key features include the orientation of the clamp jaws relative to the aortic wall and the positioning of the arterial suture lines for donor kidney attachment.

A surgical illustration depicting orthotopic renal transplantation, specifically focusing on the arterial clamping technique. The diagram shows the abdominal aorta as a central, vertical cylindrical vessel. A Satinsky surgical clamp is applied to the aorta, positioned precisely at the base of the left renal artery. This selective clamping method is designed to occlude blood flow for the creation of an anastomotic opening (approximately 8 mm from the artery base) while purposefully sparing the mesenteric arteries and the right renal artery, which are visible branching superiorly to the clamped segment. The illustration highlights the relationship between the surgical instrumentation and vascular anatomy to maintain systemic circulation and prevent lower limb or contralateral renal ischemia during the procedure. Key features include the orientation of the clamp jaws relative to the aortic wall and the positioning of the arterial suture lines for donor kidney attachment.

Diagnostic neuroimaging diagram illustrating the setup for Pulsed Arterial Spin Labeling (PASL). The image contains two panels: a sagittal view (left) and a coronal view (right) of the human head and neck, presented as T1-weighted MRI scans. Superimposed on these scans is a large blue rectangular block representing the labeling slice prescription (inversion slab), positioned over the neck region to capture inflowing blood. Within this blue slab, the major feeding arteries (carotid and vertebral arteries) are highlighted in purple, demonstrating the volume where water molecules in the blood are magnetically labeled. A light green horizontal bar is positioned higher across the cerebral cortex, indicating the imaging plane or region where tissue perfusion signal will be measured after a post-labeling delay. Key anatomical landmarks visible include the cervical spine, brainstem, cerebellum, and the base of the skull, showing the spatial relationship between the labeling site in the neck and the target imaging site in the brain. This visual serves as an educational guide for technical MRI protocol positioning in perfusion imaging.

Diagnostic neuroimaging diagram illustrating the setup for Pulsed Arterial Spin Labeling (PASL). The image contains two panels: a sagittal view (left) and a coronal view (right) of the human head and neck, presented as T1-weighted MRI scans. Superimposed on these scans is a large blue rectangular block representing the labeling slice prescription (inversion slab), positioned over the neck region to capture inflowing blood. Within this blue slab, the major feeding arteries (carotid and vertebral arteries) are highlighted in purple, demonstrating the volume where water molecules in the blood are magnetically labeled. A light green horizontal bar is positioned higher across the cerebral cortex, indicating the imaging plane or region where tissue perfusion signal will be measured after a post-labeling delay. Key anatomical landmarks visible include the cervical spine, brainstem, cerebellum, and the base of the skull, showing the spatial relationship between the labeling site in the neck and the target imaging site in the brain. This visual serves as an educational guide for technical MRI protocol positioning in perfusion imaging.

Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Searching Images

acid base disorders compensation metabolic respiratory table

This Comparison Chart displays three coronal PET scan images (a, b, and c) of the human torso, demonstrating the impact of respiratory gating on diagnostic image quality. The modality highlights metabolic activity using a grey scale representing Standardized Uptake Value (SUV) from 0 to 6. Anatomical landmarks include the liver (showing high radiotracer uptake), kidneys, spine, and pulmonary regions. Image (a) shows the scan without motion compensation, where thoracic lesions indicated by arrows appear blurred and elongated along the cranio-caudal axis due to respiratory motion. Image (b) utilizes data-driven quiescent period gating (DDG), and image (c) utilizes externally driven (RPM) quiescent period gating. In both (b) and (c), the motion-compensated images show significantly improved lesion clarity, better definition of lesion morphology, and higher overall image contrast compared to the non-gated image (a). This clinical example illustrates how respiratory gating techniques minimize motion artifacts, particularly for small pulmonary and hilar lesions, enhancing diagnostic accuracy and quantitative SUV measurements in oncology imaging.

This Comparison Chart displays three coronal PET scan images (a, b, and c) of the human torso, demonstrating the impact of respiratory gating on diagnostic image quality. The modality highlights metabolic activity using a grey scale representing Standardized Uptake Value (SUV) from 0 to 6. Anatomical landmarks include the liver (showing high radiotracer uptake), kidneys, spine, and pulmonary regions. Image (a) shows the scan without motion compensation, where thoracic lesions indicated by arrows appear blurred and elongated along the cranio-caudal axis due to respiratory motion. Image (b) utilizes data-driven quiescent period gating (DDG), and image (c) utilizes externally driven (RPM) quiescent period gating. In both (b) and (c), the motion-compensated images show significantly improved lesion clarity, better definition of lesion morphology, and higher overall image contrast compared to the non-gated image (a). This clinical example illustrates how respiratory gating techniques minimize motion artifacts, particularly for small pulmonary and hilar lesions, enhancing diagnostic accuracy and quantitative SUV measurements in oncology imaging.

Recommendation Table 52. Recommendations for acid-base homeostasis and electrolytes
<table><thead><tr><th>Recommendations</th><th>Class<sup>a</sup></th><th>Level<sup>b</sup></th><th>Ref<sup>c</sup></th></tr></thead><tbody><tr><td>Alpha-stat acid-base management should be considered in adult cardiac surgery patients with high-moderate hypothermia due to improved neurological and neurocognitive outcomes.</td><td>IIa</td><td>B</td><td>[786, 787]</td></tr><tr><td>Magnesium sulphate may be considered perioperatively for prophylaxis of postoperative arrhythmias and improved cardiac protection/tissue oxygenation.</td><td>IIb</td><td>B</td><td>[790, 792, 793]</td></tr></tbody></table>

Recommendation Table 52. Recommendations for acid-base homeostasis and electrolytes <table><thead><tr><th>Recommendations</th><th>Class<sup>a</sup></th><th>Level<sup>b</sup></th><th>Ref<sup>c</sup></th></tr></thead><tbody><tr><td>Alpha-stat acid-base management should be considered in adult cardiac surgery patients with high-moderate hypothermia due to improved neurological and neurocognitive outcomes.</td><td>IIa</td><td>B</td><td>[786, 787]</td></tr><tr><td>Magnesium sulphate may be considered perioperatively for prophylaxis of postoperative arrhythmias and improved cardiac protection/tissue oxygenation.</td><td>IIb</td><td>B</td><td>[790, 792, 793]</td></tr></tbody></table>

TABLE 2. Treatable Inborn Errors of Metabolism Associated With Global Developmental Delay and Intellectual Disability for Tier 2 Evaluation
<table><thead><tr><th>Disorder (Gene)</th><th>Clinical Features (Untreated)</th><th>Biochemical Evaluation</th></tr></thead><tbody><tr><td>Phenylketonuria(PAH)</td><td>Developmental delay/intellectual disability, autism, eczema, reduced skin and hair pigmentation, epilepsy<sup>48</sup></td><td>Plasma amino acids (increased phenylalanine)</td></tr><tr><td>Classic homocystinuria (CBS1)</td><td>Developmental delay/intellectual disability, marfanoid habitus (tall stature, scoliosis, pectus excavatum), eye lens dislocation and/or high myopia, increased risk of thrombosis<sup>49</sup></td><td>Total homocysteine (increased), plasma amino acids (increased methionine)</td></tr><tr><td>Organic acidurias</td><td>Developmental delay/intellectual disability, metabolic acidosis, hyperammonemia, failure to thrive, epilepsy, movement disorder, metabolic stroke<sup>24</sup></td><td>Urine organic acids, plasma acylcarnitines, ammonia</td></tr><tr><td>Urea cycle disorders</td><td>Episodes of hyperammonemic encephalopathy, protein aversion<sup>50</sup></td><td>Ammonia, plasma amino acids (abnormal citrulline and/or arginine), urine organic acids (+/− increased orotic acid)</td></tr><tr><td>Creatine deficiency syndromes (AGAT, GAMT, SLC6A8)</td><td>Developmental delay/intellectual disability, autism, epilepsy<sup>51</sup></td><td>Urine creatine/creatinine, plasma creatine, urine and plasma guanidinoacetate</td></tr><tr><td>Lesch-Nyhan syndrome (HPRT1)</td><td>Developmental delay/intellectual disability, autism, spasticity, movement disorder, uric acid nephropathy<sup>20</sup></td><td>Plasma uric acid (increased), urine purine and pyrimidines</td></tr><tr><td>Mucopolysaccharidoses</td><td>Developmental delay, behavioral abnormalities, coarse facial features, hepatosplenomegaly, ophthalmological findings, orthopedic anomalies (eg, progressive spine deformities)<sup>52</sup></td><td>Urine glycosaminoglycans</td></tr><tr><td>Biotinidase deficiency</td><td>Developmental delay/regression, hypotonia, ataxia, epilepsy, hearing and vision loss, skin rash, alopecia<sup>53</sup></td><td>Biotinidase enzyme activity (if not included on newborn screening or clinical suspicion)</td></tr></tbody></table>

TABLE 2. Treatable Inborn Errors of Metabolism Associated With Global Developmental Delay and Intellectual Disability for Tier 2 Evaluation <table><thead><tr><th>Disorder (Gene)</th><th>Clinical Features (Untreated)</th><th>Biochemical Evaluation</th></tr></thead><tbody><tr><td>Phenylketonuria(PAH)</td><td>Developmental delay/intellectual disability, autism, eczema, reduced skin and hair pigmentation, epilepsy<sup>48</sup></td><td>Plasma amino acids (increased phenylalanine)</td></tr><tr><td>Classic homocystinuria (CBS1)</td><td>Developmental delay/intellectual disability, marfanoid habitus (tall stature, scoliosis, pectus excavatum), eye lens dislocation and/or high myopia, increased risk of thrombosis<sup>49</sup></td><td>Total homocysteine (increased), plasma amino acids (increased methionine)</td></tr><tr><td>Organic acidurias</td><td>Developmental delay/intellectual disability, metabolic acidosis, hyperammonemia, failure to thrive, epilepsy, movement disorder, metabolic stroke<sup>24</sup></td><td>Urine organic acids, plasma acylcarnitines, ammonia</td></tr><tr><td>Urea cycle disorders</td><td>Episodes of hyperammonemic encephalopathy, protein aversion<sup>50</sup></td><td>Ammonia, plasma amino acids (abnormal citrulline and/or arginine), urine organic acids (+/− increased orotic acid)</td></tr><tr><td>Creatine deficiency syndromes (AGAT, GAMT, SLC6A8)</td><td>Developmental delay/intellectual disability, autism, epilepsy<sup>51</sup></td><td>Urine creatine/creatinine, plasma creatine, urine and plasma guanidinoacetate</td></tr><tr><td>Lesch-Nyhan syndrome (HPRT1)</td><td>Developmental delay/intellectual disability, autism, spasticity, movement disorder, uric acid nephropathy<sup>20</sup></td><td>Plasma uric acid (increased), urine purine and pyrimidines</td></tr><tr><td>Mucopolysaccharidoses</td><td>Developmental delay, behavioral abnormalities, coarse facial features, hepatosplenomegaly, ophthalmological findings, orthopedic anomalies (eg, progressive spine deformities)<sup>52</sup></td><td>Urine glycosaminoglycans</td></tr><tr><td>Biotinidase deficiency</td><td>Developmental delay/regression, hypotonia, ataxia, epilepsy, hearing and vision loss, skin rash, alopecia<sup>53</sup></td><td>Biotinidase enzyme activity (if not included on newborn screening or clinical suspicion)</td></tr></tbody></table>

A clinical photograph illustrating a specialized human body experiment architecture for respiratory motion compensation during medical imaging or radiation therapy. The setup is mounted on a Somatom Emotion Duo CT scanner couch and includes several numbered components for immobilization and signal acquisition. A: Target simulator for reproducing respiratory displacement; B: Respiratory compensating system (RSS); C: Body fix base; D: Hip fix for lower body stabilization; E: Custom thermoplastic cast used for precise patient immobilization. For signal acquisition, a strain gauge (F) is placed over the abdominal region, held by an arch-type fixture (G) and connected via a compression rod (H). This arrangement translates the physical movement of the abdomen during respiration into voltage signals. The system is designed to synchronize couch movement with the patient's breathing cycle to offset respiratory motion, ensuring more accurate diagnostic imaging or targeted dose delivery in radiation oncology.

A clinical photograph illustrating a specialized human body experiment architecture for respiratory motion compensation during medical imaging or radiation therapy. The setup is mounted on a Somatom Emotion Duo CT scanner couch and includes several numbered components for immobilization and signal acquisition. A: Target simulator for reproducing respiratory displacement; B: Respiratory compensating system (RSS); C: Body fix base; D: Hip fix for lower body stabilization; E: Custom thermoplastic cast used for precise patient immobilization. For signal acquisition, a strain gauge (F) is placed over the abdominal region, held by an arch-type fixture (G) and connected via a compression rod (H). This arrangement translates the physical movement of the abdomen during respiration into voltage signals. The system is designed to synchronize couch movement with the patient's breathing cycle to offset respiratory motion, ensuring more accurate diagnostic imaging or targeted dose delivery in radiation oncology.

Reading File
Reading File
Reading File
Searching Images

anion gap metabolic acidosis causes MUDPILES mnemonic

This composite educational image illustrates the clinical and diagnostic features of distal renal tubular acidosis (dRTA) associated with sensorineural hearing loss. (a) Data table showing results of a bicarbonate loading test, characterized by low urine-to-blood pCO2 gradient and positive urinary anion gap. (b) Renal ultrasound images of the left and right kidneys demonstrating medullary nephrocalcinosis, visualized as multiple hyperechoic foci within the renal pyramids. (c) Axial FIESTA (Fast Imaging Employing Steady-state Acquisition) cerebral MRI scan showing bilateral enlargement of the endolymphatic sacs (indicated by white arrows), a common finding in Pendred syndrome or dRTA with hearing loss. (d) Anatomical schematic of the inner ear, labeling the cochlea, vestibule, semicircular ducts, and endolymphatic duct. (e) Audiogram plot showing frequency (kHz) versus decibels (dB), depicting significant hearing impairment. The collection integrates metabolic laboratory data, diagnostic radiology (ultrasound and MRI), and functional audiological testing to present a comprehensive case of a hereditary renal-otological syndrome.

This composite educational image illustrates the clinical and diagnostic features of distal renal tubular acidosis (dRTA) associated with sensorineural hearing loss. (a) Data table showing results of a bicarbonate loading test, characterized by low urine-to-blood pCO2 gradient and positive urinary anion gap. (b) Renal ultrasound images of the left and right kidneys demonstrating medullary nephrocalcinosis, visualized as multiple hyperechoic foci within the renal pyramids. (c) Axial FIESTA (Fast Imaging Employing Steady-state Acquisition) cerebral MRI scan showing bilateral enlargement of the endolymphatic sacs (indicated by white arrows), a common finding in Pendred syndrome or dRTA with hearing loss. (d) Anatomical schematic of the inner ear, labeling the cochlea, vestibule, semicircular ducts, and endolymphatic duct. (e) Audiogram plot showing frequency (kHz) versus decibels (dB), depicting significant hearing impairment. The collection integrates metabolic laboratory data, diagnostic radiology (ultrasound and MRI), and functional audiological testing to present a comprehensive case of a hereditary renal-otological syndrome.

This diagnostic image is an axial Fluid-Attenuated Inversion Recovery (FLAIR) magnetic resonance imaging (MRI) scan of the brain. The image demonstrates prominent, symmetrical hyperintensities localized within the bilateral basal ganglia, specifically involving the putamina (indicated by white arrows). Additionally, a smaller, heterogeneous area of increased signal intensity is visible in the anterior midline of the cerebral parenchyma. These visual findings are characteristic of bilateral putaminal necrosis, often associated with acute toxic metabolic encephalopathy, such as methanol poisoning. The image highlights key radiological features used in neuroradiology for identifying toxic insults to the deep gray matter structures. It serves as an educational example for medical students and clinicians in identifying specific imaging patterns related to systemic toxicity and high-anion gap metabolic acidosis.

This diagnostic image is an axial Fluid-Attenuated Inversion Recovery (FLAIR) magnetic resonance imaging (MRI) scan of the brain. The image demonstrates prominent, symmetrical hyperintensities localized within the bilateral basal ganglia, specifically involving the putamina (indicated by white arrows). Additionally, a smaller, heterogeneous area of increased signal intensity is visible in the anterior midline of the cerebral parenchyma. These visual findings are characteristic of bilateral putaminal necrosis, often associated with acute toxic metabolic encephalopathy, such as methanol poisoning. The image highlights key radiological features used in neuroradiology for identifying toxic insults to the deep gray matter structures. It serves as an educational example for medical students and clinicians in identifying specific imaging patterns related to systemic toxicity and high-anion gap metabolic acidosis.

This pathophysiology diagram illustrates the cellular mechanism by which acidosis regulates MondoA transcriptional activity. The schematic is divided into two comparative states: 'Control' (blue background) and 'Acidosis' (red background). Key components include a mitochondrion, Hexokinase 2 (HK2), the MondoA protein, and metabolic intermediates glucose and glucose-6-phosphate (G6P). Under control conditions, mitochondrial ATP (mtATP) levels are low, and HK2 is bound to the outer mitochondrial membrane. Glucose is converted to G6P by HK2, resulting in basal MondoA interaction. In the 'Acidosis' state, a shift in pH drives a significant increase in mtATP production. This high mtATP concentration facilitates enhanced HK2 enzymatic activity at the mitochondrial surface, leading to increased production of G6P. The elevated G6P levels trigger MondoA to undergo nuclear localization and increased transcriptional activity, as indicated by a large upward arrow toward the nucleus. This diagram demonstrates how metabolic sensing of mitochondrial energy charge and cytoplasmic glucose levels are integrated via HK2 to control gene expression under conditions of metabolic stress or altered pH.

This pathophysiology diagram illustrates the cellular mechanism by which acidosis regulates MondoA transcriptional activity. The schematic is divided into two comparative states: 'Control' (blue background) and 'Acidosis' (red background). Key components include a mitochondrion, Hexokinase 2 (HK2), the MondoA protein, and metabolic intermediates glucose and glucose-6-phosphate (G6P). Under control conditions, mitochondrial ATP (mtATP) levels are low, and HK2 is bound to the outer mitochondrial membrane. Glucose is converted to G6P by HK2, resulting in basal MondoA interaction. In the 'Acidosis' state, a shift in pH drives a significant increase in mtATP production. This high mtATP concentration facilitates enhanced HK2 enzymatic activity at the mitochondrial surface, leading to increased production of G6P. The elevated G6P levels trigger MondoA to undergo nuclear localization and increased transcriptional activity, as indicated by a large upward arrow toward the nucleus. This diagram demonstrates how metabolic sensing of mitochondrial energy charge and cytoplasmic glucose levels are integrated via HK2 to control gene expression under conditions of metabolic stress or altered pH.

Searching Images

oxygenation hypoxemia PaO2 alveolar arterial gradient

This composite educational image illustrates the physiological and radiological impacts of smoke inhalation (SI) and the therapeutic effects of oxygen microbubbles (OMB). Panel A shows a bar graph demonstrating a significant decrease in peripheral oxygen saturation (SpO2) from a baseline of ~98% to ~85% following smoke inhalation. Panel B presents ventral-dorsal and lateral thoracic x-rays of an animal model. The 'Control' images show clear lung fields and distinct cardiac silhouettes. In contrast, the 'Smoke Inhalation' images demonstrate diffuse, bilateral pulmonary infiltrates and increased lung opacity, characteristic of acute lung injury. Anatomical landmarks including the spine, ribs, and sternum are visible across both views. Panels C and D provide statistical dose-response analyses for SpO2 and partial pressure of arterial oxygen (PaO2). These graphs show that intraperitoneal administration of OMB, particularly at a dose of 10% body weight/volume (BW/V), significantly improves oxygenation compared to saline controls, indicating the potential for OMB to mitigate SI-induced hypoxemia.

This composite educational image illustrates the physiological and radiological impacts of smoke inhalation (SI) and the therapeutic effects of oxygen microbubbles (OMB). Panel A shows a bar graph demonstrating a significant decrease in peripheral oxygen saturation (SpO2) from a baseline of ~98% to ~85% following smoke inhalation. Panel B presents ventral-dorsal and lateral thoracic x-rays of an animal model. The 'Control' images show clear lung fields and distinct cardiac silhouettes. In contrast, the 'Smoke Inhalation' images demonstrate diffuse, bilateral pulmonary infiltrates and increased lung opacity, characteristic of acute lung injury. Anatomical landmarks including the spine, ribs, and sternum are visible across both views. Panels C and D provide statistical dose-response analyses for SpO2 and partial pressure of arterial oxygen (PaO2). These graphs show that intraperitoneal administration of OMB, particularly at a dose of 10% body weight/volume (BW/V), significantly improves oxygenation compared to saline controls, indicating the potential for OMB to mitigate SI-induced hypoxemia.

This clinical graphic illustrates the real-time monitoring of Oxygen Reserve Index (ORI) and arterial oxygen saturation (SpO2) in a patient during the perioperative period. The chart displays two primary monitoring windows: (A) pre-oxygenation before tracheal intubation and (B) pre-oxygenation prior to extubation. The ORI (black line), a unit-less index ranging from 0.00 to 1.00, reflects oxygenation status in the moderate hyperoxic range (PaO2 ~100–200 mmHg). During initial pre-oxygenation (A), the ORI sharply rises to approximately 0.4 while SpO2 remains stable near 100%. Following intubation, the FiO2 is reduced to 35%, causing a significant drop in ORI to values fluctuating between 0.0 and 0.2, effectively avoiding hyperoxia. In phase (B), pre-oxygenation before extubation triggers a sharp spike in ORI toward its maximum value, indicating a robust oxygen reserve. This tool provides non-invasive clinical insight into oxygenation levels when SpO2 is already maximized and non-informative, allowing for safer airway management and precise titration of supplemental oxygen.

This clinical graphic illustrates the real-time monitoring of Oxygen Reserve Index (ORI) and arterial oxygen saturation (SpO2) in a patient during the perioperative period. The chart displays two primary monitoring windows: (A) pre-oxygenation before tracheal intubation and (B) pre-oxygenation prior to extubation. The ORI (black line), a unit-less index ranging from 0.00 to 1.00, reflects oxygenation status in the moderate hyperoxic range (PaO2 ~100–200 mmHg). During initial pre-oxygenation (A), the ORI sharply rises to approximately 0.4 while SpO2 remains stable near 100%. Following intubation, the FiO2 is reduced to 35%, causing a significant drop in ORI to values fluctuating between 0.0 and 0.2, effectively avoiding hyperoxia. In phase (B), pre-oxygenation before extubation triggers a sharp spike in ORI toward its maximum value, indicating a robust oxygen reserve. This tool provides non-invasive clinical insight into oxygenation levels when SpO2 is already maximized and non-informative, allowing for safer airway management and precise titration of supplemental oxygen.

This Comparison Chart consists of a series of three anteroposterior (AP) chest radiographs (labeled A, B, and C) illustrating the radiological progression of a patient undergoing Extracorporeal Membrane Oxygenation (ECMO) for Acute Respiratory Distress Syndrome (ARDS). Radiograph (A), taken before ECMO initiation, shows severe, bilateral pulmonary congestion and diffuse, ill-defined opacities consistent with widespread alveolar edema or consolidation. Radiograph (B), taken during ECMO therapy, demonstrates a moderate reduction in pulmonary opacities and improved aeration of the lung fields. Radiograph (C), captured after ECMO weaning, reveals significant resolution of congestion with clearer lung parenchyma, indicating clinical improvement. Visible medical devices throughout the sequence include an endotracheal tube, multiple electrocardiogram (ECG) leads, and various vascular catheters (including potential ECMO cannulae and central venous lines). The series highlights the role of mechanical circulatory support in managing severe hypoxemia and pulmonary edema, providing a visual timeline of lung recruitment and recovery in a critical care setting.

This Comparison Chart consists of a series of three anteroposterior (AP) chest radiographs (labeled A, B, and C) illustrating the radiological progression of a patient undergoing Extracorporeal Membrane Oxygenation (ECMO) for Acute Respiratory Distress Syndrome (ARDS). Radiograph (A), taken before ECMO initiation, shows severe, bilateral pulmonary congestion and diffuse, ill-defined opacities consistent with widespread alveolar edema or consolidation. Radiograph (B), taken during ECMO therapy, demonstrates a moderate reduction in pulmonary opacities and improved aeration of the lung fields. Radiograph (C), captured after ECMO weaning, reveals significant resolution of congestion with clearer lung parenchyma, indicating clinical improvement. Visible medical devices throughout the sequence include an endotracheal tube, multiple electrocardiogram (ECG) leads, and various vascular catheters (including potential ECMO cannulae and central venous lines). The series highlights the role of mechanical circulatory support in managing severe hypoxemia and pulmonary edema, providing a visual timeline of lung recruitment and recovery in a critical care setting.

Loading Image
Reading File
Reading File
I now have comprehensive, authoritative content from multiple textbooks. Let me compile the complete ABG learning guide:

🫁 Arterial Blood Gas (ABG) - Complete Learning Guide

Sources: Roberts & Hedges' Clinical Procedures in Emergency Medicine | Tintinalli's Emergency Medicine | Murray & Nadel's Respiratory Medicine | Symptom to Diagnosis (4th Ed.) | Fishman's Pulmonary Diseases

1. WHAT IS AN ABG?

An arterial blood gas measures the partial pressures of oxygen (PaO₂) and carbon dioxide (PaCO₂) in arterial blood, along with direct serum pH. Modern analyzers also calculate bicarbonate (HCO₃⁻), report oxygen saturation (SaO₂), and can include lactate, hemoglobin, and electrolytes.
Arterial sampling (radial, femoral, or brachial artery) is the reference standard - it reflects blood composition after pulmonary gas exchange and before peripheral tissue consumption.

2. NORMAL ABG VALUES

ParameterNormal Range
pH7.35 - 7.45
PaCO₂35 - 45 mm Hg
PaO₂80 - 100 mm Hg
HCO₃⁻22 - 26 mEq/L
SaO₂95 - 100%
Base Excess (BE)-2 to +2 mEq/L
Key anchor points: Normal pH = 7.40, Normal PaCO₂ = 40 mm Hg, Normal HCO₃⁻ = 24 mEq/L.

3. THE HENDERSON-HASSELBALCH EQUATION (The Foundation)

pH = pKa + log [HCO₃⁻ / (α × PaCO₂)]
Practical version - the Kassirer-Bleich approximation:
[H⁺] = 24 × PaCO₂ / HCO₃⁻
Where H⁺ is in nmol/L, PaCO₂ in mm Hg, HCO₃⁻ in mEq/L.
Quick pH ↔ H⁺ conversion:
  • H⁺ = 25 nmol/L → pH ≈ 7.60
  • H⁺ = 40 nmol/L → pH ≈ 7.40
  • H⁺ = 63 nmol/L → pH ≈ 7.20
The core reaction to memorize:
CO₂ + H₂O ⇌ H₂CO₃ ⇌ HCO₃⁻ + H⁺
  • ↑ PaCO₂ → reaction shifts right → ↑ H⁺ → ↓ pH = Respiratory Acidosis
  • ↓ PaCO₂ → reaction shifts left → ↓ H⁺ → ↑ pH = Respiratory Alkalosis
  • ↑ HCO₃⁻ → reaction shifts left → ↓ H⁺ → ↑ pH = Metabolic Alkalosis
  • ↓ HCO₃⁻ → reaction shifts right → ↑ H⁺ → ↓ pH = Metabolic Acidosis
(Murray & Nadel's Respiratory Medicine, p.272)

4. STEP-BY-STEP ABG INTERPRETATION

Step 1: Is the pH normal, acidotic, or alkalotic?

  • pH < 7.35 = Acidosis
  • pH 7.35-7.45 = Normal (but a mixed disorder may still exist!)
  • pH > 7.45 = Alkalosis

Step 2: Identify the primary disorder (look at PaCO₂ and HCO₃⁻)

pHPrimary DisorderClue
Low (< 7.35)Metabolic acidosisHCO₃⁻ < 24 mEq/L
Low (< 7.35)Respiratory acidosisPaCO₂ > 40 mm Hg
High (> 7.45)Metabolic alkalosisHCO₃⁻ > 24 mEq/L
High (> 7.45)Respiratory alkalosisPaCO₂ < 40 mm Hg
Tip: The component that explains the pH change is the primary disorder. The other component represents compensation.

Step 3: Is compensation appropriate? (Detect mixed disorders)

This is the most important step. Calculate the expected compensation using Winter's formula (and others below). If actual compensation ≠ predicted, a second primary disorder is present.
Primary DisorderExpected Compensation
Metabolic acidosis↓ PaCO₂ = 1.3 × ↓ HCO₃⁻ (Winter's formula)
Metabolic alkalosis↑ PaCO₂ = 0.6 × ↑ HCO₃⁻
Respiratory acidosis (acute)↑ HCO₃⁻ by 1 mEq/L per 10 mm Hg ↑ PaCO₂
Respiratory acidosis (chronic)↑ HCO₃⁻ by 4 mEq/L per 10 mm Hg ↑ PaCO₂
Respiratory alkalosis (acute)↓ HCO₃⁻ by 2 mEq/L per 10 mm Hg ↓ PaCO₂
Respiratory alkalosis (chronic)↓ HCO₃⁻ by 5 mEq/L per 10 mm Hg ↓ PaCO₂
(Roberts & Hedges, p.1734)
Key rule: Compensation brings pH toward normal but never overshoots it. If pH is fully normal with two abnormal values, suspect a mixed disorder.

Step 4: Calculate the Anion Gap (if metabolic acidosis present)

Anion Gap (AG) = Na⁺ - (Cl⁻ + HCO₃⁻)
Normal AG = 12 ± 4 mEq/L
Albumin correction (critical!): For every 1 g/dL drop in albumin below 4.4, the normal AG is 2.5 mEq/L lower. In hypoalbuminemic patients (common in ICU), uncorrected AG may mask an elevated gap.

Step 5: If AG is elevated, check the Delta-Delta ratio (Delta Gap)

The Delta-Delta helps identify a hidden second metabolic disorder inside an anion gap acidosis.
Δ-Δ = (AG - 12) / (24 - HCO₃⁻)
Δ-Δ RatioInterpretation
< 1Concurrent non-anion gap metabolic acidosis
1 - 2Pure anion gap metabolic acidosis
> 2Concurrent metabolic alkalosis

Step 6: Assess oxygenation

  • PaO₂ < 80 mm Hg = Hypoxemia
  • Calculate the A-a gradient to localize the cause:
Alveolar PO₂ (PAO₂) = (FiO₂ × [Patm - PH₂O]) - (PaCO₂ / RQ)
                     = (0.21 × 713) - (PaCO₂ / 0.8)    [at sea level, room air]
                     ≈ 150 - (PaCO₂ × 1.25)

A-a Gradient = PAO₂ - PaO₂
Normal A-a gradient = age/4 + 4 (or roughly < 10-15 mm Hg in young adults)
A-a GradientCause of Hypoxemia
NormalHypoventilation, high altitude, low FiO₂
ElevatedV/Q mismatch, diffusion defect, shunt

5. THE ACID-BASE MAP (Visual Guide)

This classic diagram plots PaCO₂ (x-axis) against pH (y-axis), with HCO₃⁻ isopleths. Each disorder occupies a distinct zone. If a patient's values fall outside all named zones, a mixed disorder is present.
Acid-Base Map - pH vs PaCO2 showing all 6 primary disorder zones plus 4 mixed disorder zones
Zone key:
  • Zone 1 (red): Mixed respiratory + metabolic acidosis
  • Zone 2 (pink): Mixed respiratory + metabolic alkalosis
  • Zone 3 (yellow): Metabolic alkalosis + respiratory acidosis
  • Zone 4 (gold): Metabolic acidosis + respiratory alkalosis
  • N = Normal point (pH 7.40, PaCO₂ 40 mm Hg)
(Roberts & Hedges' Clinical Procedures in Emergency Medicine)

6. THE FOUR PRIMARY DISORDERS IN DETAIL

A. RESPIRATORY ACIDOSIS

Definition: pH < 7.35 + PaCO₂ > 45 mm Hg (primary CO₂ retention)
Causes:
CategoryExamples
PulmonaryCOPD, asthma, pulmonary edema, pneumonia, pneumothorax, massive pleural effusion
NeuromuscularStroke, opioid/sedative overdose, sleep apnea, Guillain-Barré, myasthenia gravis, ALS, polio
Chest wallFlail chest, muscular dystrophy, morbid obesity (OHS)
Airway obstructionForeign body, laryngospasm
Compensation:
  • Acute: kidneys raise HCO₃⁻ by 1 mEq/L per 10 mm Hg rise in PaCO₂
  • Chronic (3-5 days): kidneys raise HCO₃⁻ by 4 mEq/L per 10 mm Hg rise in PaCO₂
Clinical features: CO₂ narcosis, headache, confusion, asterixis, papilledema, hypertension, tachycardia.
Treatment: Treat underlying cause. Non-invasive positive pressure ventilation (NIPPV/BiPAP) for COPD exacerbation. Intubation if severe or airway compromised.

B. RESPIRATORY ALKALOSIS

Definition: pH > 7.45 + PaCO₂ < 35 mm Hg (hyperventilation)
Causes:
CategoryExamples
PulmonaryPneumonia, PE, asthma, pulmonary edema, interstitial lung disease
ExtrapulmonaryAnxiety/pain, fever, pregnancy, CNS insult (stroke, tumor), cirrhosis, salicylate toxicity, sepsis
IatrogenicMechanical over-ventilation
Compensation:
  • Acute: kidneys lower HCO₃⁻ by 2 mEq/L per 10 mm Hg fall in PaCO₂
  • Chronic: kidneys lower HCO₃⁻ by 5 mEq/L per 10 mm Hg fall in PaCO₂
Clinical features: Paresthesias, lightheadedness, tetany (Chvostek's, Trousseau's signs - from decreased ionized Ca²⁺).
Treatment: Treat underlying cause. Breathing into a paper bag for anxiety-hyperventilation is rarely recommended in clinical settings.

C. METABOLIC ACIDOSIS

Definition: pH < 7.35 + HCO₃⁻ < 22 mEq/L (primary bicarbonate loss or acid gain)
First: Calculate the Anion Gap to split into two groups:

High Anion Gap Metabolic Acidosis (HAGMA)

Unmeasured anions accumulate (acid produced or retained).
Mnemonic: MUDPILES (or GOLDMARK)
MUDPILESGOLDMARK
MethanolGlycols (ethylene, propylene)
UremiaOxoproline (5-oxoprolinuria)
DKA / Diabetic ketoacidosisL-Lactic acidosis
ParaldehydeD-Lactic acidosis
Isoniazid / IronMethanol
Lactic acidosisAspirin (salicylates)
Ethylene glycolRenal failure (uremia)
SalicylatesKetoacidosis

Normal Anion Gap Metabolic Acidosis (NAGMA)

HCO₃⁻ is lost (directly) or HCl is added - chloride replaces bicarbonate, so gap stays normal.
Mnemonic: HARDUP or USED CARP
CauseMechanism
Diarrhea (most common)GI HCO₃⁻ loss
Renal Tubular Acidosis (RTA)Failure to reabsorb/generate HCO₃⁻
Carbonic anhydrase inhibitors (acetazolamide)Blocked renal HCO₃⁻ reabsorption
Dilutional acidosisLarge-volume normal saline infusion
Early renal failureBefore AG elevates
Ureterosigmoidostomy / GI fistulasHCO₃⁻ exchange for Cl⁻
Addison's diseaseAldosterone deficiency → H⁺ retention
Urine Anion Gap (UAG) to differentiate RTA from diarrhea:
UAG = Urine (Na⁺ + K⁺) - Urine Cl⁻
  • UAG negative (< 0): intact renal acidification = GI cause (diarrhea)
  • UAG positive (> 0): impaired renal acidification = RTA
Respiratory compensation (Winter's formula):
Expected PaCO₂ = (1.5 × HCO₃⁻) + 8 ± 2
  or: ΔPaCO₂ = 1.3 × ΔHCO₃⁻
Clinical features: Kussmaul breathing (deep, rapid), hypotension (severe), arrhythmias, bone demineralization (chronic).
Treatment: Treat underlying cause. NaHCO₃ supplementation is controversial and generally reserved for severe acidosis (pH < 7.1) or specific causes (e.g., RTA, hyperchloremic acidosis).

D. METABOLIC ALKALOSIS

Definition: pH > 7.45 + HCO₃⁻ > 26 mEq/L
Generation phase: Something causes HCO₃⁻ to rise (H⁺ loss or HCO₃⁻ gain). Maintenance phase: Kidneys fail to excrete excess HCO₃⁻ (requires volume/K⁺ depletion or mineralocorticoid excess).
Causes by urine chloride (most useful bedside test):
Urine Cl⁻ < 20 mEq/L (Chloride-responsive)Urine Cl⁻ > 20 mEq/L (Chloride-resistant)
Vomiting / NG suction (HCl loss)Primary hyperaldosteronism
Thiazide/loop diuretics (after discontinuation)Cushing's syndrome
Post-hypercapniaExogenous mineralocorticoids
Villous adenomaBartter's / Gitelman's syndromes
Severe hypokalemia
Excessive licorice ingestion
Respiratory compensation: Hypoventilation → ↑ PaCO₂ = 0.6 × ↑ HCO₃⁻
  • (PaCO₂ rarely exceeds 55 mm Hg due to hypoxic ventilatory drive)
Clinical features: Weakness, confusion, muscle cramps, hypokalemia, hypocalcemia (from alkalosis shifting Ca²⁺ binding to albumin), cardiac arrhythmias.
Treatment:
  • Chloride-responsive: IV normal saline + KCl replacement
  • Chloride-resistant: Treat underlying cause (e.g., spironolactone for hyperaldosteronism)
(Symptom to Diagnosis, 4th Ed.; Murray & Nadel's, p.2182)

7. MIXED ACID-BASE DISORDERS

A mixed disorder occurs when two or more primary disorders coexist. Clues:
  1. pH is normal but both PaCO₂ and HCO₃⁻ are abnormal
  2. Compensation is more or less than predicted
  3. The pH changes in opposite directions from what a single disorder would predict
Common mixed disorders:
CombinationClinical Example
Metabolic acidosis + Respiratory acidosisCardiac arrest, severe COPD + pneumonia
Metabolic alkalosis + Respiratory alkalosisCirrhosis with vomiting or NG suctioning
Metabolic acidosis + Metabolic alkalosisDKA + vomiting
Metabolic acidosis + Respiratory alkalosisSalicylate toxicity, sepsis
Metabolic alkalosis + Respiratory acidosisCOPD + diuretic use
Triple disorder: E.g., HAGMA + NAGMA + respiratory alkalosis is possible (use Delta-Delta gap to unmask).

8. OXYGENATION ASSESSMENT

ABG oxygenation parameters:
ParameterFormula / ValueClinical Meaning
PaO₂Direct measurementOxygen dissolved in plasma
SaO₂Measured (co-oximetry)Hemoglobin saturation
A-a gradientPAO₂ - PaO₂Lung efficiency
PaO₂/FiO₂ ratioPaO₂ ÷ FiO₂ARDS severity
CaO₂(Hgb × 1.34 × SaO₂) + (0.003 × PaO₂)Total O₂ content
P/F Ratio (PaO₂/FiO₂) for ARDS classification:
  • 300: Normal
  • 200-300: Mild ARDS
  • 100-200: Moderate ARDS
  • < 100: Severe ARDS
Causes of hypoxemia (by A-a gradient):
MechanismA-a GradientExamples
HypoventilationNormalCNS depression, neuromuscular disease
Low FiO₂NormalHigh altitude
V/Q mismatchElevatedPE, COPD, pneumonia, atelectasis
Diffusion impairmentElevatedPulmonary fibrosis
Right-to-left shuntElevated, doesn't correct with O₂ASD, intrapulmonary shunt, ARDS

9. VENOUS BLOOD GAS (VBG) - When to Use

ParameterArterial vs. Venous
pHVBG pH is ~0.03-0.05 lower than ABG - closely correlates
PaCO₂VBG PCO₂ is ~4-6 mm Hg higher - trends with ABG
PaO₂Cannot use VBG for oxygenation
LactateVBG correlates well for normal or very high values
Clinical rule: A normal VBG pH and PaCO₂ reliably excludes significant arterial hypercapnia. Markedly abnormal VBG values should be confirmed with ABG.
(Tintinalli's Emergency Medicine, p.121)

10. WORKED EXAMPLES

Example 1: Diarrhea (Metabolic Acidosis with appropriate compensation)

  • Na⁺ = 133, Cl⁻ = 118, pH = 7.26, PaCO₂ = 13, HCO₃⁻ = 5
Step 1: pH 7.26 → Acidosis Step 2: HCO₃⁻ = 5 (low), PaCO₂ not high → Primary metabolic acidosis Step 3: Expected PaCO₂ = 40 - (1.3 × [25-5]) = 40 - 26 = 14 mm Hg → actual 13 ≈ predicted → appropriate compensation, no second disorder Step 4: AG = 133 - (118+5) = 10 → Normal AG → Non-anion gap metabolic acidosis → diarrhea confirmed!

Example 2: Sepsis (Respiratory Alkalosis)

  • Na⁺ = 138, Cl⁻ = 105, pH = 7.49, PaCO₂ = 25, HCO₃⁻ = 22
Step 1: pH 7.49 → Alkalosis Step 2: PaCO₂ = 25 (low), HCO₃⁻ not elevated → Primary respiratory alkalosis Step 3: Acute compensation: expected ↓ HCO₃⁻ = (40-25)/10 × 2 = 3 mEq/L → expected HCO₃⁻ = 24-3 = 21 → actual 22 ≈ predicted → appropriate (acute) response Diagnosis: Acute respiratory alkalosis (sepsis-driven hyperventilation)

Example 3: DKA (HAGMA with mixed disorder)

  • Na⁺ = 138, Cl⁻ = 100, pH = 7.15, PaCO₂ = 20, HCO₃⁻ = 6
Step 1: pH 7.15 → Acidosis Step 2: HCO₃⁻ = 6 → Primary metabolic acidosis Step 3: Expected PaCO₂ = 1.5(6) + 8 = 17 ± 2 → actual 20 → higher than expected → suggests concurrent respiratory acidosis (or compensation inadequate) Step 4: AG = 138 - (100+6) = 32 → Elevated → High AG metabolic acidosis (DKA) Step 5: Delta-Delta = (32-12)/(24-6) = 20/18 = 1.1 → Pure anion gap acidosis
(Symptom to Diagnosis, 4th Ed.)

11. QUICK REFERENCE - THE SIX-STEP APPROACH

Step 1: pH → Acidemia or Alkalemia?
Step 2: PaCO₂ / HCO₃⁻ → Respiratory or Metabolic?
Step 3: Expected compensation → Appropriate? (If not = mixed disorder)
Step 4: Anion gap → High or Normal? (For metabolic acidosis)
Step 5: Delta-Delta → Hidden second metabolic disorder?
Step 6: PaO₂ / A-a gradient → Oxygenation status?

12. MEMORY TRICKS AT A GLANCE

TrickMeaning
ROMERespiratory Opposite, Metabolic Equal (pH and primary parameter move in same direction for metabolic, opposite for respiratory)
MUDPILESCauses of high-AG metabolic acidosis
USED CARPCauses of normal-AG metabolic acidosis
Winter's formulaExpected PaCO₂ = 1.5×HCO₃⁻ + 8 ± 2
"1-4-2-5 rule"Resp. acidosis compensation: acute ↑1, chronic ↑4; Resp. alkalosis: acute ↓2, chronic ↓5 (per 10 mmHg PaCO₂ change)

13. CRITICAL pH VALUES TO KNOW

pHSignificance
< 6.8Usually incompatible with life
< 7.1Severe acidosis - consider bicarbonate therapy
7.35Lower limit of normal
7.40Physiologic target
7.45Upper limit of normal
> 7.7Severe alkalosis - high risk of arrhythmia, tetany

Key textbook references:
  • Roberts & Hedges' Clinical Procedures in Emergency Medicine, p.1732-1734
  • Tintinalli's Emergency Medicine: A Comprehensive Study, p.121
  • Murray & Nadel's Textbook of Respiratory Medicine, p.272-2310
  • Symptom to Diagnosis: An Evidence-Based Guide, 4th Ed., p.68-73
  • Fishman's Pulmonary Diseases and Disorders
attachment
attachment

Read this report

analyse_media
Here is a full read of the report:

🧪 Lab Report - Gurukrupa Clinical Laboratory

Patient: Mrs. Priyanka Ratnadip Wasagdekar Age/Gender: 42 Years / Female Report Date: 23-Jul-2026, 05:00 PM Ref. By: Dr. Ware Rahul G. (MBBS, MD Med) UHID: 9425 | Report ID: 2026/20466

🩸 COMPLETE HAEMOGRAM

TestResultUnitNormal RangeStatus
Haemoglobin11.9g/dL11.5 - 16.5✅ Normal
RBC Count3.97million/cu.mm4.5 - 6.5🔻 Low
PCV (Haematocrit)37.5%37 - 47✅ Normal
MCV94.3fL80 - 99✅ Normal
MCH30.2pg27 - 33✅ Normal
MCHC32.0g/dL32 - 37✅ Normal (low-normal)
RDW-CV13.6%11.0 - 14.5✅ Normal
RDW-SD45.0fL10.0 - 15.0
WBC Count8300/cu.mm4000 - 11000✅ Normal
Neutrophils74%40 - 75✅ Normal
Lymphocytes23%20 - 45✅ Normal
Eosinophils01%1 - 6✅ Normal
Monocytes02%0 - 10✅ Normal
Basophils00%0 - 1✅ Normal
Platelet Count2.28lakhs/cu.mm1.50 - 4.50✅ Normal
PCT0.213%0.08 - 1.0✅ Normal
MPV9.4fL7.4 - 11.5✅ Normal
PDW16.3%10.0 - 15.0🔺 Slightly High

🍬 BLOOD GLUCOSE (RANDOM)

TestResultUnitNormal RangeStatus
Plasma Glucose (Random)118mg%70 - 140✅ Normal
Urine Glucose (Random)Nil✅ Normal

🫘 CREATININE TEST

TestResultUnitNormal RangeStatus
Creatinine0.85mg/dL0 - 1.4✅ Normal
eGFR78mL/min/1.73m²90 - 120🔻 Mildly Reduced

Summary of Abnormal Findings

FindingValueSignificance
RBC Count low (3.97 million/cu.mm)Below normal (4.5-6.5)Mild anaemia - red cells fewer than expected, though Hb and PCV are acceptable
PDW elevated (16.3%)Above normal (10-15%)Platelet Distribution Width raised - suggests platelet size variation (anisothrombia), can be seen with inflammation, iron deficiency, or reactive thrombocytosis
eGFR mildly reduced (78 mL/min/1.73m²)Below normal (90-120)Suggests mildly reduced kidney filtration function (CKD Stage G2 by KDIGO if persistent)

Key Observations

  • Haemoglobin is normal at 11.9 g/dL (just above the lower cut-off of 11.5) - technically within range but toward the lower end for a 42-year-old woman.
  • RBC count is low despite acceptable Hb - this pattern alongside a normal MCV (94.3 fL) and normal MCHC suggests the cells are adequately filled but fewer in number. This pattern is worth monitoring.
  • Kidney function - Creatinine is normal, but the eGFR of 78 is modestly below the 90-120 range. This could reflect the patient's age and body size rather than true kidney disease, but should be re-checked if not done previously.
  • Random glucose is normal at 118 mg% with no glycosuria.
  • WBC and differential are entirely normal - no infection/inflammatory signal.
⚠️ Note: This is a summary for informational purposes only. Please consult Dr. Ware Rahul G. or your treating physician to interpret these results in the context of your symptoms, medical history, and clinical examination.
attachment
attachment

Generate echocardiography report from above image

analyse_media
Here is the fully generated echocardiography report based on the image data:

🫀 2D ECHOCARDIOGRAPHY REPORT

Patient NameHAJARE, MARUTI
Age70 Years
SexMale
Date06/07/2026
Referred ByDr. Rahul Ware

A. LEFT VENTRICULAR (LV) STUDY

ParameterValueNormal RangeStatus
IVSd (Interventricular Septum - Diastole)1.0 cm0.6 - 1.1 cm✅ Normal
LVIDd (LV Internal Diameter - Diastole)4.1 cm3.9 - 5.3 cm✅ Normal
LVPWd (LV Posterior Wall - Diastole)1.1 cm0.6 - 1.1 cm✅ Normal (upper limit)
IVSs (Interventricular Septum - Systole)1.5 cm0.9 - 1.8 cm✅ Normal
LVIDs (LV Internal Diameter - Systole)2.4 cm2.0 - 3.5 cm✅ Normal
LVPWs (LV Posterior Wall - Systole)1.4 cm1.0 - 1.8 cm✅ Normal
EDV - Teichholz76 ml67 - 155 ml✅ Normal
ESV - Teichholz19 ml22 - 58 ml✅ Normal
EF - Teichholz75 %55 - 75 %Normal (Hyperdynamic)
%FS (Fractional Shortening)43 %25 - 45 %✅ Normal
SV (Stroke Volume)57 ml60 - 100 ml🔻 Low-normal
LV Assessment: Normal LV size with hyperdynamic systolic function. Wall thickness is at the upper limit of normal suggesting mild concentric remodeling, consistent with the patient's age (70 years) and possible hypertensive background.

B. LEFT ATRIUM / AORTA (LA/Ao)

ParameterValueNormal RangeStatus
Aortic Root Diameter2.7 cm2.0 - 3.7 cm✅ Normal
LA Diameter3.8 cm1.9 - 4.0 cm✅ Normal (borderline)
LA/Ao Ratio1.40< 1.3🔺 Mildly Elevated
D-E Excursion1.9 cm> 1.5 cm✅ Normal
E-F Slope0.05 m/s
EPSS (E-Point Septal Separation)0.5 cm< 1.0 cm✅ Normal
LA Assessment: Left atrium is mildly enlarged relative to the aortic root (LA/Ao ratio 1.40, normal < 1.3), suggesting mild left atrial dilatation. This may be related to diastolic dysfunction or longstanding pressure elevation.

C. MITRAL VALVE

ParameterValueNormal RangeStatus
MV E Velocity0.57 m/s0.6 - 1.3 m/s🔻 Low
MV Deceleration Time (DecT)265 ms150 - 220 ms🔺 Prolonged
MV Deceleration Slope2.2 m/s²
MV A Velocity0.77 m/s0.2 - 0.6 m/s🔺 Elevated
MV E/A Ratio0.740.8 - 1.5🔺 Reversed (< 0.8)
E/E' (Lateral)10.53< 8 (normal), > 14 (elevated filling)⚠️ Intermediate
E' (Tissue Doppler)0.05 m/s> 0.10 m/s🔻 Reduced
Mitral Valve Assessment: Mitral valve shows Grade I diastolic dysfunction (Impaired Relaxation pattern):
  • E < A with E/A ratio 0.74 (reversed)
  • Prolonged deceleration time (265 ms)
  • Reduced E' (0.05 m/s) indicating impaired myocardial relaxation
  • E/E' of 10.53 - intermediate zone (indeterminate filling pressures)
  • No significant stenosis or regurgitation pattern identified

D. AORTIC VALVE

ParameterValueNormal RangeStatus
AV Vmax (Peak Velocity)1.48 m/s< 2.0 m/s✅ Normal
AV maxPG (Max Pressure Gradient)8.73 mmHg< 20 mmHg✅ Normal
Aortic Valve Assessment: Aortic valve velocities and pressure gradients are within normal limits. No significant aortic stenosis detected.

E. TRICUSPID VALVE

ParameterValueNormal RangeStatus
TR Vmax (Tricuspid Regurgitation Peak Velocity)1.45 m/s< 2.8 m/s✅ Normal
TR maxPG (Max Pressure Gradient)8.46 mmHg✅ Normal
RAP (Right Atrial Pressure)10.00 mmHg3 - 8 mmHg🔺 Mildly Elevated
RVSP (RV Systolic Pressure)18.46 mmHg< 35 mmHgNormal
Tricuspid / RV Assessment: Mild tricuspid regurgitation with normal RV systolic pressure. RAP is mildly elevated at 10 mmHg. No pulmonary hypertension detected (RVSP 18.46 mmHg is normal).

F. PULMONARY VALVE

ParameterValueNormal RangeStatus
PV Vmax1.48 m/s< 1.9 m/s✅ Normal
PV maxPG8.80 mmHg< 16 mmHg✅ Normal
Pulmonary Valve Assessment: Normal pulmonary valve flow velocities and gradients. No pulmonary stenosis.

SUMMARY & IMPRESSION

1. Left Ventricular Systolic Function: NORMAL (Hyperdynamic)
  • EF = 75%, %FS = 43% - preserved and hyperdynamic systolic function.
2. Left Ventricular Diastolic Function: GRADE I DIASTOLIC DYSFUNCTION (Impaired Relaxation)
  • E/A ratio reversed at 0.74, prolonged DT (265 ms), reduced E' (0.05 m/s)
  • E/E' = 10.53 - indeterminate filling pressures
  • Consistent with age-related and possibly hypertension-related diastolic impairment
3. Left Atrium: Mildly Dilated (LA/Ao ratio 1.40)
4. Aortic Valve: Normal - no stenosis
5. Mitral Valve: Normal morphology with diastolic dysfunction pattern on Doppler
6. Pulmonary Artery Pressure: Normal (RVSP 18.46 mmHg)
7. No Pericardial Effusion / Wall Motion Abnormality noted (from visible data)

RECOMMENDATIONS

  • Correlate clinically with symptoms of exertional dyspnoea, orthopnoea, or ankle oedema which may reflect diastolic heart failure (HFpEF - Heart Failure with Preserved Ejection Fraction).
  • Optimize blood pressure control if hypertensive, as this is the most common cause of diastolic dysfunction in a 70-year-old male.
  • Follow-up echocardiogram in 1-2 years or earlier if symptoms worsen.
  • Consider BNP/NT-proBNP if clinically indicated.

⚠️ Disclaimer: This report is generated from raw machine data captured on screen. The "Conventional Colour & Tissue Doppler" section and impression text were not fully visible in the image. Final interpretation should be made by a qualified cardiologist in conjunction with clinical findings.

Does orris care have API?

Searching the Web

Orris care API developer access medical AI

Based on my search, here's what I found:
Orris Care does not currently have a publicly available API.
Orris Care (orris.care) is a Clinical Decision Support System (CDSS) that is still in beta stage as of 2026. The product is focused on direct use by doctors and medical professionals through its platform interface. There is no publicly documented developer API, SDK, or API key program listed on their website or in any public developer resources.
Key facts about Orris Care right now:
  • Founded May 2025 (US entity) / Feb 2025 (Indian entity - Orriumisocare Pvt Ltd)
  • Small team of 2-10 employees, still in beta
  • Product is designed for point-of-care clinical decision support
  • Mentioned goal of "Integration with hospital workflows" - suggesting API/integration capabilities may be on the roadmap, but not yet publicly available
What you can do:
  • Reach out to their team directly at hi@orris.care to ask about API access, partnership, or integration possibilities
  • Visit orris.care for the latest updates
If you're looking for a medical AI API available right now, EvidenceMD offers an OpenAI-compatible medical reasoning API with peer-reviewed citations that is publicly accessible.

Do you need help connecting your lab data or imaging systems to clinical AI tools?

Asking for Preferences
That's a strong starting point - a clinician who's already building. Here's a practical roadmap based on exactly what you need:

🏗️ Building a Clinical AI Integration - Your Roadmap

You want to connect lab data + imaging (ECHO) to AI interpretation tools. Here's how to approach each layer:

1. 📄 Lab Report Ingestion (Like Gurukrupa Lab)

The challenge: Lab machines print PDFs or paper reports. You need structured data from them.
Options:
ApproachHowTools
Image/PDF → AI extractionPhoto or scan → OCR + AI parsingGoogle Vision API, AWS Textract, Azure Form Recognizer
Direct LIS integrationIf the lab uses software (Meditech, SoftClinic, etc.) ask for HL7 or CSV exportHL7 v2 / FHIR R4
What you just did hereUpload photo → Orris reads itAlready working!
Recommended for India: Most small labs use SoftClinic, Wingsoft, or LabSoft - all support PDF/CSV export. Build a simple parser on top.

2. 🫀 ECHO / Imaging Machine Integration

The challenge: ECHO machines (like the one showing Hajare Maruti's data) output to a screen or print. Modern machines output DICOM files.
Options:
ApproachHow
DICOM receiverMost ECHO machines can push to a PACS server via DICOM. Set up an open-source PACS (Orthanc is free) to receive files
Screen capture (what you're doing now)Photo → AI reads values - simple but not scalable
Structured report exportSome machines export XML/PDF structured reports - check your ECHO machine's model
AI on DICOM videoAdvanced - AI reads the actual echo loops (requires specialized CV models)
Quick win: Ask your ECHO machine vendor (GE, Philips, Mindray) if it supports DICOM SR (Structured Report) export - this gives you the measurements as structured data automatically.

3. 🤖 AI Interpretation Layer

Once data is structured, you need an AI to interpret it. Your options:
ToolBest ForAPI?
Orris CareClinical Q&A, report interpretationNot yet (contact hi@orris.care)
EvidenceMD APIEvidence-based clinical reasoning✅ Yes, OpenAI-compatible
OpenAI GPT-4oGeneral interpretation with custom prompts✅ Yes
Google Health AI (Med-PaLM)Medical reasoningLimited access
Build your ownFine-tune on your own patient dataRequires ML expertise

4. 🔗 Putting It Together - A Simple Architecture

Lab Machine / ECHO Machine
        ↓
  PDF / DICOM / Photo
        ↓
  OCR / DICOM Parser
        ↓
  Structured JSON Data
  {Hb: 11.9, EF: 75%, ...}
        ↓
  AI Interpretation API
  (EvidenceMD / GPT-4o / Orris)
        ↓
  Clinical Report / Alert
  → Doctor's Phone / EMR

5. 🇮🇳 India-Specific Considerations

  • ABDM (Ayushman Bharat Digital Mission) - India's national health stack supports FHIR R4. Building ABDM-compliant can unlock interoperability with PHR apps and government systems.
  • ABHA integration - Linking patient records to their ABHA ID is the direction India's health system is moving.
  • Data privacy - DPDP Act 2023 applies. Patient data must be handled with consent.

What I'd Suggest as Your Next Step

Since you're already building, the fastest path is:
  1. Standardize your data input - get lab PDFs + ECHO structured reports
  2. Use a Vision AI API (AWS Textract or Google Vision) to parse reports automatically - this replaces manual photo uploads
  3. Call EvidenceMD or GPT-4o API with the parsed data for interpretation
  4. Display results in a simple web/mobile dashboard for the clinic

Would you like help with any specific part - the parsing code, the AI prompt design for lab interpretation, DICOM setup, or the ABDM/FHIR integration? I can dive into whichever layer you're working on right now.
This is a shared conversation. Sign in to Orris to start your own chat.